Rani Therapeutics Holdings (RANI) Return on Assets (2021 - 2026)
Rani Therapeutics Holdings (RANI) posted quarterly Return on Assets of 0.01% for Q1 2026, up 1.0% year-over-year from 0.01% in Q1 2025, and up 41.1% quarter-over-quarter from 0.01% in Q4 2025.
Rani Therapeutics Holdings (RANI) Return on Assets (2021 - 2026) Analysis & Trends
Rani Therapeutics Holdings' Return on Assets history runs 6 years deep, the most recent figure standing at 0.01% for Q1 2026.
- In Q1 2026, Return on Assets rose 1.0% year-over-year to 0.01%; the TTM figure through Mar 2026 stood at 0.01% (up 1.0% YoY), while the FY2025 annual figure was 0.02%, down 1.0% from the prior year.
- Return on Assets for Q1 2026 stood at 0.01%, up from 0.01% in the prior quarter.
- The five-year high for Return on Assets was 0.01% in Q1 2022, with the low at 0.04% in Q3 2025.
- The 5-year median for Return on Assets is 0.01% (2023), against an average of 0.01%.
- The sharpest annual moves came in 2025 and 2026: Return on Assets declined 2 bps in 2025, then rose 1 bps in 2026.
- Rani Therapeutics Holdings' Return on Assets stood at 0.01% in 2022, then slumped by 80 bps to 0.01% in 2023, then plunged by 38 bps to 0.01% in 2024, then gained by 11 bps to 0.01% in 2025, then jumped by 41 bps to 0.01% in 2026.
- Business Quant data shows RANI's Return on Assets at 0.01% in Q1 2026, 0.01% in Q4 2025, and 0.04% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROA (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 0.00% |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 0.00% |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 0.00% |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 0.00% |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 0.00% |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 0.00% |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 0.00% |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 0.00% |
| 10 | Rani Therapeutics Holdings | 160.33 Mn | 160.33 Mn | - | -0.01% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -0.01% |
| Mar 31, 2026 | -0.01% |
| Dec 31, 2025 | -0.01% |
| Sep 30, 2025 | -0.04% |
| Jun 30, 2025 | -0.03% |
| Mar 31, 2025 | -0.02% |
| Dec 31, 2024 | -0.01% |
| Sep 30, 2024 | -0.01% |
| Jun 30, 2024 | -0.01% |
| Mar 31, 2024 | -0.01% |
| Dec 31, 2023 | -0.01% |
| Sep 30, 2023 | -0.01% |
| Jun 30, 2023 | -0.01% |
| Mar 31, 2023 | -0.01% |
| Dec 31, 2022 | -0.01% |
| Sep 30, 2022 | -0.01% |
| Jun 30, 2022 | -0.01% |
| Mar 31, 2022 | -0.01% |
| Dec 31, 2021 | 0.00% |
| Sep 30, 2021 | 0.00% |